Skip to main content
Signal8

Krishnamohan Neha

SEC insider (Form 3/4/5 filer). CIK 0001866171. CFO and Chief Business Officer at Latigo Biotherapeutics, Inc. (LTGO) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in WESTLAKE VILLAGE, CA.

Companies Krishnamohan Neha has filed insider reports for

  • Latigo Biotherapeutics, Inc. (LTGO): Officer, CFO and Chief Business Officer
  • Arcutis Biotherapeutics, Inc. (ARQT): Director
  • Artiva Biotherapeutics, Inc. (ARTV): Officer, Chief Financial Officer
Krishnamohan Neha profile photo

Krishnamohan Neha

CIK: 0001866171

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (18.2%)

Position reduction

Option Exercises (M)2 (18.2%)

Derivative conversions

Awards (A)4 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (27.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Latigo Biotherapeutics, Inc. logo
LTGO

Latigo Biotherapeutics, Inc.

Officer
Arcutis Biotherapeutics, Inc. logo
ARQT

Arcutis Biotherapeutics, Inc.

Director
Artiva Biotherapeutics, Inc. logo
ARTV

Artiva Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Jun 5, 2026
    Award
    Direct
    5.8K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Nov 15, 2025
    Tax Payment
    Direct
    3.5K shares at avg. $3.25$11K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 13, 2025
    Exercise
    Direct
    12.2K shares at avg. $7.51$92K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 13, 2025
    Sale
    Direct
    39.3K shares at avg. $23.19$911K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 13, 2025
    Sale
    Direct
    1.2K shares at avg. $23.37$29K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 13, 2025
    Exercise
    Direct
    27.1K shares at avg. $8.63$233K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Aug 15, 2025
    Tax Payment
    Direct
    5.8K shares at avg. $2.75$16K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Jun 12, 2025
    Award
    Direct
    7.6K shares-
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    May 15, 2025
    Tax Payment
    Direct
    1.3K shares at avg. $2.13$3K
  • Artiva Biotherapeutics, Inc. logo
    ARTV

    Artiva Biotherapeutics, Inc.

    Feb 26, 2025
    Award
    Direct
    60K shares-

1-10 of 11